Literature DB >> 28177155

A Chaperone Complex Formed by HSP47, FKBP65, and BiP Modulates Telopeptide Lysyl Hydroxylation of Type I Procollagen.

Ivan Duran1,2, Jorge H Martin1, Mary Ann Weis3, Pavel Krejci4, Peter Konik5, Bing Li6, Yasemin Alanay7, Caressa Lietman8, Brendan Lee8,9, David Eyre3, Daniel H Cohn1,6, Deborah Krakow10,11.   

Abstract

Lysine hydroxylation of type I collagen telopeptides varies from tissue to tissue, and these distinct hydroxylation patterns modulate collagen cross-linking to generate a unique extracellular matrix. Abnormalities in these patterns contribute to pathologies that include osteogenesis imperfecta (OI), fibrosis, and cancer. Telopeptide procollagen modifications are carried out by lysyl hydroxylase 2 (LH2); however, little is known regarding how this enzyme regulates hydroxylation patterns. We identified an ER complex of resident chaperones that includes HSP47, FKBP65, and BiP regulating the activity of LH2. Our findings show that FKBP65 and HSP47 modulate the activity of LH2 to either favor or repress its activity. BiP was also identified as a member of the complex, playing a role in enhancing the formation of the complex. This newly identified ER chaperone complex contributes to our understanding of how LH2 regulates lysyl hydroxylation of type I collagen C-telopeptides to affect the quality of connective tissues.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28177155      PMCID: PMC5466459          DOI: 10.1002/jbmr.3095

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  40 in total

1.  Comparison of proteins expressed by Pseudomonas aeruginosa strains representing initial and chronic isolates from a cystic fibrosis patient: an analysis by 2-D gel electrophoresis and capillary column liquid chromatography-tandem mass spectrometry.

Authors:  S L Hanna; N E Sherman; M T Kinter; J B Goldberg
Journal:  Microbiology       Date:  2000-10       Impact factor: 2.777

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Elevated formation of pyridinoline cross-links by profibrotic cytokines is associated with enhanced lysyl hydroxylase 2b levels.

Authors:  Annemarie J van der Slot; Ernst A van Dura; Elly C de Wit; Jeroen De Groot; Tom W J Huizinga; Ruud A Bank; Anne-Marie Zuurmond
Journal:  Biochim Biophys Acta       Date:  2004-10-05

Review 4.  Lysine post-translational modifications of collagen.

Authors:  Mitsuo Yamauchi; Marnisa Sricholpech
Journal:  Essays Biochem       Date:  2012       Impact factor: 8.000

5.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

6.  Osteoarthritis-related fibrosis is associated with both elevated pyridinoline cross-link formation and lysyl hydroxylase 2b expression.

Authors:  D F G Remst; E N Blaney Davidson; E L Vitters; A B Blom; R Stoop; J M Snabel; R A Bank; W B van den Berg; P M van der Kraan
Journal:  Osteoarthritis Cartilage       Date:  2012-10-13       Impact factor: 6.576

7.  Disentangling mechanisms involved in collagen pyridinoline cross-linking: The immunophilin FKBP65 is critical for dimerization of lysyl hydroxylase 2.

Authors:  Rutger A F Gjaltema; Miesje M van der Stoel; Miriam Boersema; Ruud A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-13       Impact factor: 11.205

8.  Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma.

Authors:  Daniela Pankova; Yulong Chen; Masahiko Terajima; Mark J Schliekelman; Brandi N Baird; Monica Fahrenholtz; Li Sun; Bartley J Gill; Tegy J Vadakkan; Min P Kim; Young-Ho Ahn; Jonathon D Roybal; Xin Liu; Edwin Roger Parra Cuentas; Jaime Rodriguez; Ignacio I Wistuba; Chad J Creighton; Don L Gibbons; John M Hicks; Mary E Dickinson; Jennifer L West; K Jane Grande-Allen; Samir M Hanash; Mitsuo Yamauchi; Jonathan M Kurie
Journal:  Mol Cancer Res       Date:  2015-12-02       Impact factor: 5.852

9.  HSP47 and FKBP65 cooperate in the synthesis of type I procollagen.

Authors:  Ivan Duran; Lisette Nevarez; Anna Sarukhanov; Sulin Wu; Katrina Lee; Pavel Krejci; Maryann Weis; David Eyre; Deborah Krakow; Daniel H Cohn
Journal:  Hum Mol Genet       Date:  2014-12-15       Impact factor: 5.121

10.  Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum.

Authors:  A Nakai; M Satoh; K Hirayoshi; K Nagata
Journal:  J Cell Biol       Date:  1992-05       Impact factor: 10.539

View more
  21 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation.

Authors:  Steven Mumm; Gary S Gottesman; Deborah Wenkert; Philippe M Campeau; Angela Nenninger; Margaret Huskey; Vinieth N Bijanki; Deborah J Veis; Aileen M Barnes; Joan C Marini; Marina Stolina; Fan Zhang; William H McAlister; Michael P Whyte
Journal:  Bone       Date:  2019-08-28       Impact factor: 4.398

Review 3.  The fibrotic tumor stroma.

Authors:  Mitsuo Yamauchi; Thomas H Barker; Don L Gibbons; Jonathan M Kurie
Journal:  J Clin Invest       Date:  2018-01-02       Impact factor: 14.808

4.  Novel compound heterozygous mutations in SERPINH1 cause rare autosomal recessive osteogenesis imperfecta type X.

Authors:  Y Song; D Zhao; X Xu; F Lv; L Li; Y Jiang; O Wang; W Xia; X Xing; M Li
Journal:  Osteoporos Int       Date:  2018-03-09       Impact factor: 4.507

5.  Role of Glycosyltransferase 25 Domain 1 in Type I Collagen Glycosylation and Molecular Phenotypes.

Authors:  Masahiko Terajima; Yuki Taga; Marnisa Sricholpech; Yukako Kayashima; Noriko Sumida; Nobuyo Maeda; Shunji Hattori; Mitsuo Yamauchi
Journal:  Biochemistry       Date:  2019-12-05       Impact factor: 3.162

Review 6.  The heat shock protein 47 as a potential biomarker and a therapeutic agent in cancer research.

Authors:  Beatriz Dal Pont Duarte; Diego Bonatto
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-20       Impact factor: 4.553

7.  Heat shock protein 47 and 65-kDa FK506-binding protein weakly but synergistically interact during collagen folding in the endoplasmic reticulum.

Authors:  Yoshihiro Ishikawa; Paul Holden; Hans Peter Bächinger
Journal:  J Biol Chem       Date:  2017-08-31       Impact factor: 5.157

8.  FK506-Binding Protein 13 Expression Is Upregulated in Interstitial Lung Disease and Correlated with Clinical Severity. A Potentially Protective Role.

Authors:  Victor Tat; Ehab A Ayaub; Anmar Ayoub; Megan Vierhout; Safaa Naiel; Manreet K Padwal; Soumeya Abed; Olivia Mekhael; Karun Tandon; Spencer D Revill; Tamana Yousof; Pierre-Simon Bellaye; Philipp S Kolb; Anna Dvorkin-Gheva; Asghar Naqvi; Jean-Claude Cutz; Nathan Hambly; Jiro Kato; Martha Vaughan; Joel Moss; Martin R J Kolb; Kjetil Ask
Journal:  Am J Respir Cell Mol Biol       Date:  2021-02       Impact factor: 6.914

9.  FKBP65-dependent peptidyl-prolyl isomerase activity potentiates the lysyl hydroxylase 2-driven collagen cross-link switch.

Authors:  Yulong Chen; Masahiko Terajima; Priyam Banerjee; Houfu Guo; Xin Liu; Jiang Yu; Mitsuo Yamauchi; Jonathan M Kurie
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

Review 10.  Collagen transport and related pathways in Osteogenesis Imperfecta.

Authors:  Lauria Claeys; Silvia Storoni; Marelise Eekhoff; Mariet Elting; Lisanne Wisse; Gerard Pals; Nathalie Bravenboer; Alessandra Maugeri; Dimitra Micha
Journal:  Hum Genet       Date:  2021-06-24       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.